Treace Medical Concepts (TMCI) EBITDA (2020 - 2026)
Treace Medical Concepts (TMCI) posted EBITDA of -$17.2 million for Q1 2026, down 189.89% on a QoQ basis from -$5.9 million in Q4 2025, and down 10.17% year-over-year from -$19.1 million in Q1 2025.
Treace Medical Concepts (TMCI) EBITDA (2020 - 2026) Analysis & Trends
Treace Medical Concepts' EBITDA history runs 7 years deep, the most recent figure standing at -$17.2 million for Q1 2026.
- Quarterly EBITDA fell 10.17% year-over-year to -$17.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$55.7 million (down 6.57% YoY) and the FY2025 annual result came in at -$54.2 million, up 2.75% from the prior year.
- EBITDA was -$17.2 million for Q1 2026 at Treace Medical Concepts, down from -$5.9 million in the prior quarter.
- Across five years, EBITDA topped out at -$204000.0 in Q4 2024 and bottomed at -$21.4 million in Q2 2024.
- A 5-year average of -$12.5 million and a median of -$13.8 million in 2023 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2024 — EBITDA jumped 96.99% — and 2025, when it slumped 2802.94%.
- Treace Medical Concepts' EBITDA stood at -$3.5 million in 2022, then tumbled by 93.94% to -$6.8 million in 2023, then soared by 96.99% to -$204000.0 in 2024, then slumped by 2802.94% to -$5.9 million in 2025, then plunged by 189.89% to -$17.2 million in 2026.
- Business Quant data shows TMCI's EBITDA at -$17.2 million in Q1 2026, -$5.9 million in Q4 2025, and -$15.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.08 Bn | 176.78 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 68.58 Bn | 67.13 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 255.30 Mn |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.08 Bn | 1.98 Bn | 515.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 282.15 Mn |
| 10 | Treace Medical Concepts | 266.44 Mn | 214.59 Mn | 37.41 Mn | -17.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.17 Mn |
| Dec 31, 2025 | -5.92 Mn |
| Sep 30, 2025 | -15.68 Mn |
| Jun 30, 2025 | -16.97 Mn |
| Mar 31, 2025 | -15.58 Mn |
| Dec 31, 2024 | -204,000.00 |
| Sep 30, 2024 | -15.13 Mn |
| Jun 30, 2024 | -21.38 Mn |
| Mar 31, 2024 | -18.97 Mn |
| Dec 31, 2023 | -6.78 Mn |
| Sep 30, 2023 | -17.82 Mn |
| Jun 30, 2023 | -13.05 Mn |
| Mar 31, 2023 | -13.78 Mn |
| Dec 31, 2022 | -3.50 Mn |
| Sep 30, 2022 | -11.32 Mn |
| Jun 30, 2022 | -11.93 Mn |
| Mar 31, 2022 | -8.10 Mn |
| Dec 31, 2021 | -5.60 Mn |
| Sep 30, 2021 | -5.46 Mn |
| Jun 30, 2021 | -4.05 Mn |